companydata.dkcompanydata.dk

ABBLO PHARMA ApS: Financial statements 2021

CVR: 34080534

Source: annual report 2021, Danish Business Authority

01/01/202131/12/2021

ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 740,462 and a net result of DKK 285,238 compared with DKK 213,834 the year before. That is an increase of 97.1% compared with the year before. Equity in the 2021 report amounted to DKK -629,191. The company had 1 employee in the financial year.

Gross Profit
DKK 740,462
Profit/Loss
DKK 285,238
Equity
DKK -629,191
Total Assets
DKK 882,250
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-740 t.285 t.-629 t.1
2020-376 t.214 t.-914 t.1
2019-306 t.100 t.-1.1 mio.1
2018-146 t.12 t.-1.2 mio.1
2017-120 t.-84 t.-1.2 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ABBLO PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

ABBLO PHARMA ApS: The 2020 annual report is outMar 25, 2021

ABBLO PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 375,630, and the net result was DKK 213,834.

About ABBLO PHARMA ApS

ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.

Source: annual report 2025, Danish Business Authority